Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle

C. H. Lin, C. M. Yang, F. N. Ko, Y. C. Wu, C. M. Teng

研究成果: 雜誌貢獻文章

17 引文 (Scopus)

摘要

The antimuscarinic properties of liriodenine, isolated from Fissistigma glaucescens, were compared with methoctramine (cardioselective M2 antagonist) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, smooth muscle selective M3 antagonist) by radioligand binding tests, functional tests and measurements of second messenger generation in canine cultured tracheal smooth muscle cells. Liriodenine, pirenzepine, methoctramine and 4-DAMP displaced [3H]-N-methyl scopolamine ([3H]-NMS) binding in a concentration-dependent manner with K values of 2.2 ± 0.4 x 10-6, 3.3 ± 0.7 x 10-7, 8.9 ± 2.3 x 10-8 and 2.3 ± 0.6 x 10-9 M, respectively. The curves for competitive inhibition of [3H]-NMS with liriodenine, methoctramine and 4-DAMP were best fitted according to a two site model of binding, but pirenzepine was best fitted according to a model with one site. Liriodenine and 4-DAMP displayed a high affinity for blocking tracheal contraction (pK(B) = 5.9 and 9.1, respectively) and inositol phosphate formation (pK(B) = 6.0 and 8.9, respectively), but a low affinity for antagonism of cyclic AMP inhibition (pK(B) = 4.7 and 7.8, respectively). Methoctramine blocked cyclic AMP inhibition with a high affinity (pK(B) = 7.4), but it antagonized tracheal contraction and inositol phosphate formation with a low affinity (pK(B) = 6.1 and 6.0, respectively). In conclusion, both M2 and M3 muscarinic receptor subtypes coexist in canine tracheal smooth muscle and are coupled to the inhibition of cyclic AMP formation and phosphoinositide breakdown, respectively. The antimuscarinic characteristics of liriodenine are similar to those of 4-DAMP. It may act as a selective M3 receptor antagonist in canine tracheal smooth muscle.
原文英語
頁(從 - 到)1464-1470
頁數7
期刊British Journal of Pharmacology
113
發行號4
出版狀態已發佈 - 1994
對外發佈Yes

指紋

Annonaceae
Muscarinic Antagonists
Smooth Muscle
Canidae
Cyclic AMP
Pirenzepine
Inositol Phosphates
Muscarinic M3 Receptors
Muscarinic M2 Receptors
Scopolamine Hydrobromide
Second Messenger Systems
Phosphatidylinositols
Smooth Muscle Myocytes
Binding Sites
4-diphenylacetoxy-1,1-dimethylpiperidinium
liriodenine
methoctramine

ASJC Scopus subject areas

  • Pharmacology

引用此文

Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle. / Lin, C. H.; Yang, C. M.; Ko, F. N.; Wu, Y. C.; Teng, C. M.

於: British Journal of Pharmacology, 卷 113, 編號 4, 1994, p. 1464-1470.

研究成果: 雜誌貢獻文章

Lin, C. H. ; Yang, C. M. ; Ko, F. N. ; Wu, Y. C. ; Teng, C. M. / Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle. 於: British Journal of Pharmacology. 1994 ; 卷 113, 編號 4. 頁 1464-1470.
@article{51ef9727bc934c3a99226d918fdf2592,
title = "Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle",
abstract = "The antimuscarinic properties of liriodenine, isolated from Fissistigma glaucescens, were compared with methoctramine (cardioselective M2 antagonist) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, smooth muscle selective M3 antagonist) by radioligand binding tests, functional tests and measurements of second messenger generation in canine cultured tracheal smooth muscle cells. Liriodenine, pirenzepine, methoctramine and 4-DAMP displaced [3H]-N-methyl scopolamine ([3H]-NMS) binding in a concentration-dependent manner with K values of 2.2 ± 0.4 x 10-6, 3.3 ± 0.7 x 10-7, 8.9 ± 2.3 x 10-8 and 2.3 ± 0.6 x 10-9 M, respectively. The curves for competitive inhibition of [3H]-NMS with liriodenine, methoctramine and 4-DAMP were best fitted according to a two site model of binding, but pirenzepine was best fitted according to a model with one site. Liriodenine and 4-DAMP displayed a high affinity for blocking tracheal contraction (pK(B) = 5.9 and 9.1, respectively) and inositol phosphate formation (pK(B) = 6.0 and 8.9, respectively), but a low affinity for antagonism of cyclic AMP inhibition (pK(B) = 4.7 and 7.8, respectively). Methoctramine blocked cyclic AMP inhibition with a high affinity (pK(B) = 7.4), but it antagonized tracheal contraction and inositol phosphate formation with a low affinity (pK(B) = 6.1 and 6.0, respectively). In conclusion, both M2 and M3 muscarinic receptor subtypes coexist in canine tracheal smooth muscle and are coupled to the inhibition of cyclic AMP formation and phosphoinositide breakdown, respectively. The antimuscarinic characteristics of liriodenine are similar to those of 4-DAMP. It may act as a selective M3 receptor antagonist in canine tracheal smooth muscle.",
keywords = "Fissistigma glaucescens, liriodenine, muscarinic receptor antagonist, tracheal smooth muscle cells",
author = "Lin, {C. H.} and Yang, {C. M.} and Ko, {F. N.} and Wu, {Y. C.} and Teng, {C. M.}",
year = "1994",
language = "English",
volume = "113",
pages = "1464--1470",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle

AU - Lin, C. H.

AU - Yang, C. M.

AU - Ko, F. N.

AU - Wu, Y. C.

AU - Teng, C. M.

PY - 1994

Y1 - 1994

N2 - The antimuscarinic properties of liriodenine, isolated from Fissistigma glaucescens, were compared with methoctramine (cardioselective M2 antagonist) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, smooth muscle selective M3 antagonist) by radioligand binding tests, functional tests and measurements of second messenger generation in canine cultured tracheal smooth muscle cells. Liriodenine, pirenzepine, methoctramine and 4-DAMP displaced [3H]-N-methyl scopolamine ([3H]-NMS) binding in a concentration-dependent manner with K values of 2.2 ± 0.4 x 10-6, 3.3 ± 0.7 x 10-7, 8.9 ± 2.3 x 10-8 and 2.3 ± 0.6 x 10-9 M, respectively. The curves for competitive inhibition of [3H]-NMS with liriodenine, methoctramine and 4-DAMP were best fitted according to a two site model of binding, but pirenzepine was best fitted according to a model with one site. Liriodenine and 4-DAMP displayed a high affinity for blocking tracheal contraction (pK(B) = 5.9 and 9.1, respectively) and inositol phosphate formation (pK(B) = 6.0 and 8.9, respectively), but a low affinity for antagonism of cyclic AMP inhibition (pK(B) = 4.7 and 7.8, respectively). Methoctramine blocked cyclic AMP inhibition with a high affinity (pK(B) = 7.4), but it antagonized tracheal contraction and inositol phosphate formation with a low affinity (pK(B) = 6.1 and 6.0, respectively). In conclusion, both M2 and M3 muscarinic receptor subtypes coexist in canine tracheal smooth muscle and are coupled to the inhibition of cyclic AMP formation and phosphoinositide breakdown, respectively. The antimuscarinic characteristics of liriodenine are similar to those of 4-DAMP. It may act as a selective M3 receptor antagonist in canine tracheal smooth muscle.

AB - The antimuscarinic properties of liriodenine, isolated from Fissistigma glaucescens, were compared with methoctramine (cardioselective M2 antagonist) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, smooth muscle selective M3 antagonist) by radioligand binding tests, functional tests and measurements of second messenger generation in canine cultured tracheal smooth muscle cells. Liriodenine, pirenzepine, methoctramine and 4-DAMP displaced [3H]-N-methyl scopolamine ([3H]-NMS) binding in a concentration-dependent manner with K values of 2.2 ± 0.4 x 10-6, 3.3 ± 0.7 x 10-7, 8.9 ± 2.3 x 10-8 and 2.3 ± 0.6 x 10-9 M, respectively. The curves for competitive inhibition of [3H]-NMS with liriodenine, methoctramine and 4-DAMP were best fitted according to a two site model of binding, but pirenzepine was best fitted according to a model with one site. Liriodenine and 4-DAMP displayed a high affinity for blocking tracheal contraction (pK(B) = 5.9 and 9.1, respectively) and inositol phosphate formation (pK(B) = 6.0 and 8.9, respectively), but a low affinity for antagonism of cyclic AMP inhibition (pK(B) = 4.7 and 7.8, respectively). Methoctramine blocked cyclic AMP inhibition with a high affinity (pK(B) = 7.4), but it antagonized tracheal contraction and inositol phosphate formation with a low affinity (pK(B) = 6.1 and 6.0, respectively). In conclusion, both M2 and M3 muscarinic receptor subtypes coexist in canine tracheal smooth muscle and are coupled to the inhibition of cyclic AMP formation and phosphoinositide breakdown, respectively. The antimuscarinic characteristics of liriodenine are similar to those of 4-DAMP. It may act as a selective M3 receptor antagonist in canine tracheal smooth muscle.

KW - Fissistigma glaucescens

KW - liriodenine

KW - muscarinic receptor antagonist

KW - tracheal smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0028148846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028148846&partnerID=8YFLogxK

M3 - Article

C2 - 7889303

AN - SCOPUS:0028148846

VL - 113

SP - 1464

EP - 1470

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -